Tip 1 Diyabetli Çocuklarda Lipohipertrofi Sıklığı ve Risk Faktörlerinin İncelenmesi.

Objective: Drug therapy recommended for people with Type 1 diabetes is insulin. One of the complications of insulins medication is lipohypertrophy. The aim of this study was to analyze the frequency and risk factors of lipohypertrophy in the children with Type 1 diabetes. Material and Methods: A descriptive cross sectional study design was used. The study was conducted between June-October 2017 in a Diabetes Education and Monitoring Center in a Children's Hospital in Turkey. A descriptive information form was used to collect the data. Ethical approval and permission were obtained from the ethics committee and the institution, respectively. As a result of the study, number, percentage and chi-square analysis were used to evaluate the data. Results: In this study, 61.1% of the patients were found to have lipohipthrophy, and it was determined that lipohipertrophy was mostly found in arms (73.61%), arms were followed by abdominal region, its incidence was 18.5% in the abdominal region. However, it was determined that the duration of diabetes diagnosis, duration of diabetes treatment and field rotation were significant factors which affect the development of lipohipertrophy. Conclusion: In this study, it was determined that the incidence of lipohypertrophy in the children with Type 1 diabetes is substantial, lipohipertrophy was mostly observed in eyes. In addition, in children with Type 1 diabetes, diabet nurses should be careful about the duration of diabetes diagnosis, duration of insulin treatment and field rotation. It is recommended to perform randomized controlled interventional studies on how to prevent the development of lipohypertrophy. [ABSTRACT FROM AUTHOR]